Korean Diabetes J.  2010 Dec;34(6):338-339. 10.4093/kdj.2010.34.6.338.

Correlations of Glucose Levels in Interstitial Fluid Estimated by Continuous Glucose Monitoring Systems and Venous Plasma

• Kim BJ

• KMID: 2222360
• DOI: http://doi.org/10.4093/kdj.2010.34.6.338

Abstract

No abstract available.

MeSH Terms

Extracellular Fluid
Glucose
Plasma
Glucose

Reference

1. Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab. 1999. 12:Suppl 3. 751–758.

2. Melki V, Hanaire-Broutin H. Indication of CGMS (Continuous Glucose Monitoring System) in the functionnal investigations of adult type 1 diabetic patients. Diabetes Metab. 2001. 27(5 Pt 1):618–623.

3. Schiaffini R, Ciampalini P, Fierabracci A, Spera S, Borrelli P, Bottazzo GF, Crino A. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev. 2002. 18:324–329.

4. Buhling KJ, Winkel T, Wolf C, Kurzidim B, Mahmoudi M, Wohlfarth K, Wascher C, Schink T, Dudenhausen JW. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). J Perinat Med. 2005. 33:125–131.

5. Kerssen A, De Valk HW, Visser GH. Validation of the Continuous Glucose Monitoring System (CGMS) by the use of two CGMS simultaneously in pregnant women with type 1 diabetes mellitus. Diabetes Technol Ther. 2005. 7:699–706.

6. Baek YH, Jin HY, Lee KA, Kang SM, Kim WJ, Kim MG, Park JH, Chae SW, Baek HS, Park TS. The correlation and accuracy of glucose levels between interstitial fluid and venous plasma by continuous glucose monitoring system. Korean Diabetes J. 2010. 34:350–358.

7. Chetty VT, Almulla A, Odueyungbo A, Thabane L. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in type I diabetic patients: a systematic review. Diabetes Res Clin Pract. 2008. 81:79–87.

8. Gerritsen M. Problems associated with subcutaneously implanted glucose sensors. Diabetes Care. 2000. 23:143–145.

9. Rowinski P, Rowinska M, Heller A. Liquid crystal membranes for serum-compatible diabetes management-assisting subcutaneously implanted amperometric glucose sensors. Anal Chem. 2008. 80:1746–1755.

10. Koschwanez HE, Yap FY, Klitzman B, Reichert WM. In vitro and in vivo characterization of porous poly-L-lactic acid coatings for subcutaneously implanted glucose sensors. J Biomed Mater Res A. 2008. 87:792–807.

11. Salzsieder E, Augstein P, Vogt L, Kohnert KD, Heinke P, Freyse EJ, Azim Ahmed A, Metwali Z, Salman I, Attef O. Telemedicine-based KADIS combined with CGMS has high potential for improving outpatient diabetes care. J Diabetes Sci Technol. 2007. 1:511–521.

12. Hanaire H. Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop. Diabetes Metab. 2006. 32(5 Pt 2):534–538.

13. Renard E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol. 2002. 2:708–716.